Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma

American Journal of Surgical Pathology

Volumn 33, Issue 4, 2009, Pages 542-550

  Hornick, Jason L ^a   Dal Cin, Paola ^a   Fletcher, Christopher D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Epithelioid sarcoma; INI1; Malignant rhabdoid tumor; Snf5

Indexed keywords

DNA BINDING PROTEIN; PROTEIN INI1; UNCLASSIFIED DRUG; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; EPITHELIOID SARCOMA; HISTIOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LARGE CELL LYMPHOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MELANOMA; MESOTHELIOMA; METASTASIS; PANCREAS CARCINOMA; PERIPHERAL NERVE TUMOR; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RHABDOID TUMOR; SOFT TISSUE CANCER; STOMACH CARCINOMA; TESTIS CARCINOMA; ADENOCARCINOMA; EMBRYONAL CARCINOMA; FEMALE; INFANT; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; SARCOMA; SOFT TISSUE TUMOR;

ADENOCARCINOMA; CARCINOMA, EMBRYONAL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 63849343469     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181882c54     Document Type: Article

References (30)

1. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330.
2. Chase DR, Enzinger FM. Epithelioid sarcoma. diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 1985;9: 241-263.
3. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652.
4. Cordoba JC, Parham DM, Meyer WH, et al. A new cytogenetic finding in an epithelioid sarcoma, t(8;22)(q22;q11). Cancer Genet Cytogenet. 1994;72:151-154.
5. Debiec-Rychter M, Sciot R, Hagemeijer A. Common chromosome aberrations in the proximal type of epithelioid sarcoma. Cancer Genet Cytogenet. 2000;123:133-136.
6. Enzinger FM. Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.
7. Feely MG, Fidler ME, Nelson M, et al. Cytogenetic findings in a case of epithelioid sarcoma and a review of the literature. Cancer Genet Cytogenet. 2000;119:155-157.
8. Fisher C. Epithelioid sarcoma of enzinger. Adv Anat Pathol. 2006;13: 114-121.
9. Fletcher CD, Beham A, Bekir S, et al. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 1991;15:915-924.
10. Fletcher CD, Unni KK, Mertens F. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
11. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol. 2007;31:1813-1824.
12. Guillou L, Wadden C, Coindre JM, et al. ''Proximal-type'' epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21: 130-146.
13. Haberler C, Laggner U, Slavc I, et al. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol. 2006;30:1462-1468.
14. Hasegawa T, Matsuno Y, Shimoda T, et al. Proximal-type epi-thelioid sarcoma: a clinicopathologic study of 20 cases. Mod Pathol. 2001;14:655-663.
15. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485-1491.
16. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004; 28:644-650.
17. Laskin WB, Weiss SW, Bratthauer GL. Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma). Am J Surg Pathol. 1991;15:1136-1145.
18. Lualdi E, Modena P, Debiec-Rychter M, et al. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer. 2004;41:283-290.
19. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22:683-697.
20. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.
21. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012-4019.
22. Quezado MM, Middleton LP, Bryant B, et al. Allelic loss on chromosome 22q in epithelioid sarcomas. Hum Pathol. 1998;29: 604-608.
23. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer. 2004;4:133-142.
24. Roberts CW, Leroux MM, Fleming MD, et al. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2: 415-425.
25. Rousseau-Merck MF, Versteege I, Legrand I, et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res. 1999;59: 3152-3156.
26. Sevenet N, Sheridan E, Amram D, et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet. 1999;65:1342-1348.
27. Sigauke E, Rakheja D, Maddox DL, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol. 2006;19:717-725.
28. Sonobe H, Ohtsuki Y, Sugimoto T, et al. Involvement of 8q, 22q, and monosomy 21 in an epithelioid sarcoma. Cancer Genet Cyto-genet. 1997;96:178-180.
29. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394: 203-206.
30. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995;12:233-248.